Over-expression of bcl-xL gene in human gastric adenomas and carcinomas

International Journal of Cancer

Volumn 68, Issue 6, 1996, Pages 727-730

  Kondo, Shinya ^a   Shinomura, Yasuhisa ^a   Kanayama, Shuji ^a   Higashimoto, Yoshifumi ^a   Miyagawa, Jun Ichiro ^a   Minami, Takeshi ^a   Kiyohara, Tatsuya ^a   Zushi, Shinichiro ^a   Kitamura, Shinji ^a   Isozaki, Koji ^a   Matsuzawa, Yuji ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BCL2L1 PROTEIN, HUMAN; MESSENGER RNA; ONCOPROTEIN; PROTEIN BCL 2; PROTEIN BCL X; RNA; RNA DIRECTED DNA POLYMERASE;

ADENOMA; ADULT; AGED; ARTICLE; BIOSYNTHESIS; CARCINOMA; CHEMISTRY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; PATHOLOGY; POLYMERASE CHAIN REACTION; PROTO ONCOGENE; STOMACH TUMOR; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN TISSUE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CARCINOMA;

ADENOMA; ADULT; AGED; AGED, 80 AND OVER; BCL-X PROTEIN; CARCINOMA; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, BCL-2; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA, MESSENGER; RNA, NEOPLASM; RNA-DIRECTED DNA POLYMERASE; STOMACH NEOPLASMS;

EID: 0030300113     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19961211)68:6<727::AID-IJC6>3.0.CO;2-5     Document Type: Article

References (18)

1. BOISE, L.H., GONZÁLEZ-GARCÍA, M., POSTEMA, C.E., DING, L., LINDSTEN, T., TURKA, L.A., MAO, X., NÚÑEZ, G. and THOMPSON, C.B., bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell, 74, 597-608 (1993).
2. BRONNER, M.P., CULIN, C., REED, J.C. and FURTH, E.E., The bcl-2 proto-oncogene and the gastrointestinal-epithelial-tumor progression model. Amer. J. Pathol. 146, 20-26 (1995).
3. L is expressed in neuroblastoma cells and modulates chemotherapy-induced apoptosis. Cancer Res., 55, 2576-2582 (1995).
4. GARCIA, I., MARINOU, I., TSUJIMOTO, Y. and MARTINOU, J.C., Prevention of programmed cell death of sympathetic neurons by the bcl-2 proto-oncogene. Science, 258, 302-304 (1992).
5. L is the major bcl-x mRNA form expressed during murine development and its product localizes to mitochondria. Development, 120, 3033-3042 (1994).
6. KINOSHITA, T., YOKOTA, T., ARAI, K.-I. and MIYAJIMA, A., Regulation of bcl-2 expression by oncogenic ras protein in hematopoietic cells. Oncogene, 10, 2207-2212 (1995).
7. KONDO, S., IMAMURA, I., SHINOMURA, Y., MATSUZAWA, Y. and FUKUI, H., Determination of histidine decarboxylase mRNA in various rat tissues by the polymerase chain reaction. Inflamm. Res., 44, 111-115 (1995a).
8. KONDO, S., SHINOMURA, Y., KANAYAMA, S., HIGASHIMOTO, Y., KIYOHARA, T., YASUNAGA, Y., KITAMURA, S., UEYAMA, H., IMAMURA, I., FUKUI, H. and MATSUZAWA, Y., Helicobacter pylori increases gene expression of hepatocyte growth factor in human gastric mucosa. Biochem. biophys. Res. Commun., 210, 960-965 (1995b).
9. KRAJEWSKI, S., KRAJEWSKA, M., SHABAIK, A., WANG, H.-G., IRIE, S., FONG, L. and REED, J.C., Immunohistochemical analysis of in vivo patterns of bcl-x expression. Cancer Res., 54, 5501-5507 (1994).
10. LAURÉN, P., The two histological main types of gastric carcinoma, diffuse and so-called intestinal-type carcinoma: an attempt at a histoclinical classification. Acta pathol. microbiol. Scand., 64, 31-49 (1965).
11. LAUWERS, G.Y., SCOTT, G.V. and HENDRICKS, J., Immunohistochemical evidence of aberrant bcl-2 protein expression in gastric epithelial dysplasia. Cancer, 73, 2900-2904 (1994).
12. LAUWERS, G.Y., SCOTT, G.V. and KARPEH, M.S., Immunohistochemical evaluation of bcl-2 protein expression in gastric adenocarcinomas. Cancer, 75, 2209-2213 (1995).
13. MINAMI, T., TOJO, H., SHINOMURA, Y., TARUI, S. and OKAMOTO, M., Raised serum activity of phospholipase A2 immunochemically related to group-II enzyme in inflammatory bowel disease: its correlation with disease activity of Crohn's disease and ulcerative colitis. Gut, 33, 914-921 (1992).
14. MOTOYAMA, N., WANG, F., ROTH, K.A., SAWA, H., NAKAYAMA, K.-I., NAKAYAMA, K., NEGISHI, I., SENJU, S., ZHANG, Q., FUJII, S. and LOH, D. Y., Massive cell death of immature hematopoietic cells and neurons in bcl-x-deficient mice. Science, 267, 1506-1510 (1995).
15. NANUS, D.M., KELSEN, D.P., MENTLE, I.R., ALTORKI, N. and ALBINO, A.P., Infrequent point mutations of ras oncogenes in gastric cancers. Gastroenterology, 98, 955-960 (1990).
16. SAEGUSA, M., TAKANO, Y. and OKAYASU, I., bcl-2 expression and its association with cell kinetics in human gastric carcinomas and intestinal metaplasia. J. Cancer Res. clin. Oncol., 121, 357-363 (1995).
17. TSUJIMOTO, Y., COSSMAN, J., JAFFE, E. and CROCE, C.M., Involvement of the bcl-2 gene in human follicular lymphoma. Science, 228, 1440-1443 (1985).
18. VAUX, D.L., CORY, S. and ADAMS, J.M., bcl-2 promotes the survival of hematopoietic cells and cooperates with c-myc to immortalize pre-B cells. Nature (Lond.), 335, 440-442 (1988).